Skip to main content
# Title Department Research Member Research Year
421 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2019
422 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
423 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2019
424 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
425 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019
426 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
427 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2019
428 Complication versus Radicality in Papillary Thyroid Cancer Surgery: How to Keep the Balance? Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2019
429 Sensitvity of flowcytometry immunphenotyping compared to Bone marrow morphology in diagnosis of multiple myeloma Department of Clinical Pathology Dr. Shimaa Gafer Mansour Hasan 2019
430 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019